GMILogo_Vertical-Gradient.png
Airless Tires Market worth over $200mn by 2024: Global Market Insights, Inc.
February 07, 2018 07:00 ET | Global Market Insights, Inc
Sellbyville, Delaware, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Airless Tire Market is set to reach USD 200 million by 2024; according to a new research report by Global Market Insights, Inc. Global...
GMILogo_Vertical-Gradient.png
Steering Wheel Switches Market to hit $4bn by 2024: Global Market Insights, Inc.
January 22, 2018 06:00 ET | Global Market Insights, Inc
Sellbyville, Delaware, Jan. 22, 2018 (GLOBE NEWSWIRE) -- Steering Wheel Switches Market is set to reach USD 4 billion by 2024; according to a new research report by Global Market Insights, Inc....
GMILogo_Vertical-Gradient.png
Automotive Decorative Exterior Trim Market worth $27bn by 2024: Global Market Insights, Inc.
January 03, 2018 03:00 ET | Global Market Insights, Inc
Sellbyville, Delaware, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Global Automotive Decorative Exterior Trim Market is set to reach USD 27 billion by 2024; according to a new research report by Global...
GMILogo_Vertical-Gradient.png
Electrical Steering Column Lock Market worth $31bn by 2024: Global Market Insights, Inc.
November 13, 2017 06:00 ET | Global Market Insights, Inc
Ocean View, Delaware, Nov. 13, 2017 (GLOBE NEWSWIRE) -- Electrical Steering Column Lock Market is set to cross USD 31 billion by 2024; according to a new research report by Global Market...
Towers_Craig highres
UT Medical Center Announces Published Research Showing Evidence of Vast Hepatitis C Virus Transmission via Snorting Straws
July 28, 2016 09:42 ET | The University of Tennessee Medical Center
KNOXVILLE, Tenn., July 28, 2016 (GLOBE NEWSWIRE) -- Officials with The University of Tennessee Medical Center (UTMC) have announced evidence that the sharing of snorting utensils, such as straws, when...
Idenix Pharmaceuticals logo
Idenix Reports Favorable Resistance Profile for IDX719, a Potent, Pan-Genotypic HCV NS5A Inhibitor, at EASL Meeting
April 24, 2013 08:00 ET | Idenix Pharmaceuticals
CAMBRIDGE, Mass., April 24, 2013 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of...
CDC Recommends One-Time Hepatitis C Test for All Baby Boomers
August 16, 2012 12:52 ET | CDC Foundation
Industry and community partners applaud CDC's work to protect people from viral hepatitis, support CDC's efforts through Faces of Hepatitis video stories project ATLANTA, Aug. 16, 2012 (GLOBE...
Stellar Biotechnologies to Present at ICAAC 2012 Conference on September 9 - 12, 2012
June 20, 2012 09:05 ET | Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Jun 20, 2012) - Stellar Biotechnologies, Inc. ("Stellar") (TSX VENTURE: KLH) (PINKSHEETS: SBOTF) (FRANKFURT: RBT) is pleased to announce that Stellar scientists will...
Immune Network Ltd Logo
Immunitor Phase 2b imm01 Trial Enrollment Scheduled to Complete Next Week
November 01, 2010 09:42 ET | Immune Network Ltd
VANCOUVER, British Columbia, Nov. 1, 2010 (GLOBE NEWSWIRE) -- Immune Network Ltd. (Pink Sheets:IMMFF), a company in the business of discovery and development of immune-based therapies, today announced...
GlobeImmune's Hepatitis C Product Candidate Improves End of Treatment Response in All IL-28 B Genotypes, With the Greatest Effect in the Hardest-to-Treat Patients
April 19, 2010 07:00 ET | GlobeImmune
LOUISVILLE, CO--(Marketwire - April 19, 2010) -  GlobeImmune Inc. announced Phase 2b data for GI-5005, the Company's investigational Tarmogen® product for hepatitis C virus (HCV) infection,...